Carbohydrate intake correlated with increased breast cancer risk in urban setting (Shanghai).

Screening mammography over the last quarter century has more than doubled the rate at which women in the U.S. have been identified with early-stage breast cancer; has artificially inflated the cure rate; and has had little impact on the reduction in breast cancer deaths and the rate at which women present with late-stage cancer or metastatic cancer. Screening mammography has led to the overdiagnosis of an estimated one million women who were told they have early-stage cancer – most of whom underwent surgery, radiation, hormone therapy, molecularly-targeted therapy and in some cases chemotherapy – for a “cancer” that was never destined to progress to late-stage. Screening mammography costs 4 billion dollars a year in the U.S.. The U.S. Preventive Services Task Force guidelines are more appropriate recommending 13 scans between the ages 50 and 75 at two year intervals.